Table 3.
Physical normal function (n = 46) | Physical dysfunction (n = 21) | P value | |
---|---|---|---|
Myositis-specific autoantibodies, number (%) | |||
Anti-ARS | 16 (34) | 6 (29) | 0.62 |
Anti-MDA5 | 7 (15) | 0 (0) | 0.09 |
Anti-Mi-2 | 1 (2) | 1 (5) | 0.53 |
Anti-NXP-2 | 2 (4) | 0 (0) | 1.00 |
Anti-SRP | 3 (7) | 6 (29) | 0.02 |
Anti-TIF1-γ | 3 (7) | 1 (5) | 0.89 |
Myositis-associated autoantibodies, number (%) | 7 (21) | 6 (14) | 0.38 |
Anti-Ku | 3 (7) | 0 (0) | 0.55 |
Anti-U1-snRNP | 6 (13) | 4 (19) | 0.71 |
Anti-SS-A | 21 (46) | 9 (43) | 1.00 |
Physical dysfunction was defined as a J-HAQ-DI score greater than 0.5.
Statistical analyses were performed using the Mann-Whitney U test.
P values <0.05.
PM: polymyositis; DM: dermatomyositis; ARS: aminoacyl-tRNA synthetase; MDA5: melanoma differentiation-associated gene 5; NXP-2: nuclear matrix protein-2; SRP: signal recognition particle; TIF1-γ: transcriptional intermediary factor 1-γ.